slides · global inventory
Callout
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 96,741
Current window 84,241-84,270
Pages 3,225
Rows per page 30
Component
84,241-84,270 of 96,741
17
Slide 17 of a presentation; includes product imagery and specific clinical acronym definitions in the footer.AstraZeneca | Results Presentation Deck | 39 slides · AstraZeneca
Conference presentation Investor relations Beat · SatisfactionLoop · Golden Circle1 hit
22
Includes a stacked bar chart for Farxiga revenue by region and a line chart for Lokelma US market share.AstraZeneca | Results Presentation Deck | 39 slides · AstraZeneca
Conference presentation Investor relations Beat · Visualization1 hit
23
Includes product-specific performance metrics and regional/market share drivers.AstraZeneca | Results Presentation Deck | 39 slides · AstraZeneca
Conference presentation Investor relations Beat · Visualization1 hit
26
The slide uses a three-column layout to compare three distinct therapeutic assets.AstraZeneca | Results Presentation Deck | 39 slides · AstraZeneca
Conference presentation Investor relations Beat · Visualization1 hit
29
The slide uses a three-column structure to summarize the value proposition of the rare disease segment.AstraZeneca | Results Presentation Deck | 39 slides · AstraZeneca
Conference presentation Investor relations 1 hit
30
The slide uses an icon-grid layout to represent strategic focus areas for collaboration.AstraZeneca | Results Presentation Deck | 39 slides · AstraZeneca
Conference presentation Investor relations 1 hit
13
The waterfall chart shows cash flow movements including operational cash, capex, tax, dividends, and share buybacks.Auto Trader Group | Results Presentation Deck | 32 slides · Auto Trader
Conference presentation Investor relations 1 hit
06
The slide uses a dual-track timeline approach to show organizational milestones above the line and debt paydown milestones below the line.Bausch Health Companies | Investor Conference Presentation Deck | 25 slides · Bausch Health
Conference presentation Investor relations Beat · Problem & ComplicationLoop · Why Now1 hit
07
The slide uses a process diagram to show how various corporate actions contribute to a central 'Path to Deleveraging'.Bausch Health Companies | Investor Conference Presentation Deck | 25 slides · Bausch Health
Conference presentation Investor relations Beat · Problem & ComplicationLoop · Why Now1 hit
08
Includes headshots of leadership, a donut chart of revenue segments, and a list of key products.Bausch Health Companies | Investor Conference Presentation Deck | 25 slides · Bausch Health
Conference presentation Investor relations Beat · Evidence & ProofLoop · Mece Breakdown1 hit
09
Includes headshots of key executives, a revenue pie chart, and a list of post-separation details.Bausch Health Companies | Investor Conference Presentation Deck | 25 slides · Bausch Health
Conference presentation Investor relations Beat · Evidence & ProofLoop · Mece Breakdown1 hit
10
Includes headshots of leadership team and logos of key product brands.Bausch Health Companies | Investor Conference Presentation Deck | 25 slides · Bausch Health
Conference presentation Investor relations Beat · Evidence & ProofLoop · Mece Breakdown1 hit
09
Includes a callout box highlighting specific GAAP and non-GAAP cash flow figures.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
10
Includes footnotes detailing specific debt adjustments and divestiture impacts.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
13
Includes detailed assumptions for expenses, tax rates, share counts, and cash items.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
16
Bausch Health Companies | Results Presentation Deck | 91 slidesBausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · SatisfactionLoop · Quick Win Big Bet1 hit
18
Includes clinical trial data (MOJAVE study) and market opportunity context.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · SatisfactionLoop · Quick Win Big Bet1 hit
19
Bausch Health Companies | Results Presentation Deck | 91 slidesBausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · SatisfactionLoop · Quick Win Big Bet1 hit
23
Includes a map-based visualization of regional product performance and a donut chart for revenue breakdown.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · SatisfactionLoop · Quick Win Big Bet1 hit
27
Includes product imagery for Solta Medical brands (Thermage, Clear + Brilliant, Fraxel, Vaser).Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · SatisfactionLoop · Quick Win Big Bet1 hit
32
Includes disclaimer about non-retouched photos and medical source credits.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
35
The slide uses a flow diagram to show how business lines were reallocated between two reporting periods.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
44
Includes non-GAAP metrics and segment-specific performance data.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
46
The slide highlights a 1% organic revenue decline for the segment.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
47
Includes segment-specific revenue and operating expense breakdown.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
48
The slide includes a specific callout for the revenue decline of the WELLBUTRIN/APLENZIN product line.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
50
Includes non-GAAP metrics and segment-specific growth rates.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
51
Includes non-GAAP metrics like EBITA and organic growth.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
52
Includes non-GAAP metrics like EBITA and organic growth.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit
53
Includes non-GAAP metrics like EBITA and organic growth.Bausch Health Companies | Results Presentation Deck | 91 slides · Bausch Health
Conference presentation Investor relations Beat · Action1 hit